Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001437749-16-041352
Filing Date
2016-11-08
Accepted
2016-11-08 10:59:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 8-A12B dffn20161108_8a12b.htm 8-A12B 55182
  Complete submission text file 0001437749-16-041352.txt   56475
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-37942 | Film No.: 161980339
SIC: 2834 Pharmaceutical Preparations